These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30272642)

  • 1. Exploring the Potential of Mesenchymal Stem Cell Sheet on The Development of Hepatocellular Carcinoma In Vivo.
    Alshareeda AT; Alsowayan B; Almubarak A; Alghuwainem A; Alshawakir Y; Alahmed M
    J Vis Exp; 2018 Sep; (139):. PubMed ID: 30272642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of cell sheet technique on the development of hepatocellular carcinoma in rat models.
    Alshareeda AT; Sakaguchi K; Abumaree M; Mohd Zin NK; Shimizu T
    PLoS One; 2017; 12(8):e0184004. PubMed ID: 28850615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased migration of human mesenchymal stromal cells by autocrine motility factor (AMF) resulted in enhanced recruitment towards hepatocellular carcinoma.
    Bayo J; Fiore E; Aquino JB; Malvicini M; Rizzo M; Peixoto E; Andriani O; Alaniz L; Piccioni F; Bolontrade M; Podhajcer O; Garcia MG; Mazzolini G
    PLoS One; 2014; 9(4):e95171. PubMed ID: 24736611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
    Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
    Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human umbilical cord perivascular cells exhibited enhanced migration capacity towards hepatocellular carcinoma in comparison with bone marrow mesenchymal stromal cells: a role for autocrine motility factor receptor.
    Bayo J; Fiore E; Aquino JB; Malvicini M; Rizzo M; Peixoto E; Alaniz L; Piccioni F; Bolontrade M; Podhajcer O; Garcia MG; Mazzolini G
    Biomed Res Int; 2014; 2014():837420. PubMed ID: 25147818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor promotion through the mesenchymal stem cell compartment in human hepatocellular carcinoma.
    Hernanda PY; Pedroza-Gonzalez A; van der Laan LJ; Bröker ME; Hoogduijn MJ; Ijzermans JN; Bruno MJ; Janssen HL; Peppelenbosch MP; Pan Q
    Carcinogenesis; 2013 Oct; 34(10):2330-40. PubMed ID: 23740837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The distinct roles of mesenchymal stem cells in the initial and progressive stage of hepatocarcinoma.
    Zong C; Zhang H; Yang X; Gao L; Hou J; Ye F; Jiang J; Yang Y; Li R; Han Z; Wei L
    Cell Death Dis; 2018 Mar; 9(3):345. PubMed ID: 29497038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line.
    Li GC; Ye QH; Xue YH; Sun HJ; Zhou HJ; Ren N; Jia HL; Shi J; Wu JC; Dai C; Dong QZ; Qin LX
    Cancer Sci; 2010 Dec; 101(12):2546-53. PubMed ID: 20942864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma.
    Niess H; Bao Q; Conrad C; Zischek C; Notohamiprodjo M; Schwab F; Schwarz B; Huss R; Jauch KW; Nelson PJ; Bruns CJ
    Ann Surg; 2011 Nov; 254(5):767-74; discussion 774-5. PubMed ID: 22042469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming.
    Liu Y; Ren H; Zhou Y; Shang L; Zhang Y; Yang F; Shi X
    J Exp Clin Cancer Res; 2019 May; 38(1):228. PubMed ID: 31142342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells seldomly fuse with hepatocellular carcinoma cells and are mainly distributed in the tumor stroma in mouse models.
    Li GC; Ye QH; Dong QZ; Ren N; Jia HL; Qin LX
    Oncol Rep; 2013 Feb; 29(2):713-9. PubMed ID: 23232668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of CCR1 gene overexpression on the migration of bone marrow - derived mesenchymal stem cells towards hepatocellular carcinoma].
    Gao Y; Huang XL; Zhang L; Deng L; Yin AH; Sun BC; Lu S
    Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):354-359. PubMed ID: 28763842
    [No Abstract]   [Full Text] [Related]  

  • 13. Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy.
    Yin Z; Jiang K; Li R; Dong C; Wang L
    Mol Cancer; 2018 Dec; 17(1):178. PubMed ID: 30593276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bone marrow-derived mesenchymal stromal cells on hepatoma.
    Abd-Allah SH; Shalaby SM; El-Shal AS; Elkader EA; Hussein S; Emam E; Mazen NF; El Kateb M; Atfy M
    Cytotherapy; 2014 Sep; 16(9):1197-206. PubMed ID: 24985939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and Validation of Hepatocellular Carcinoma (HCC) Xenograft tumor as a Suitable Liver Cancer Model for Preclinical Mesenchymal Stem Cell Studies.
    Hajighasemlou S; Pakzad S; Ai J; Muhammadnejad S; Mirmoghtadaei M; Hosseinzadeh F; Gharibzadeh S; Kamali A; Ahmadi A; Verdi J
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1627-1631. PubMed ID: 29936790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemically Infused Mesenchymal Stem Cells Show Different Homing Profiles in Healthy and Tumor Mouse Models.
    Xie C; Yang Z; Suo Y; Chen Q; Wei D; Weng X; Gu Z; Wei X
    Stem Cells Transl Med; 2017 Apr; 6(4):1120-1131. PubMed ID: 28205428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of mesenchymal stem cells in the occurrence, development, and therapy of hepatocellular carcinoma.
    Zhang X; Li N; Zhu Y; Wen W
    Cancer Med; 2022 Feb; 11(4):931-943. PubMed ID: 34981659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal Stem Cell-Mediated Delivery of an Oncolytic Adenovirus Enhances Antitumor Efficacy in Hepatocellular Carcinoma.
    Yoon AR; Hong J; Li Y; Shin HC; Lee H; Kim HS; Yun CO
    Cancer Res; 2019 Sep; 79(17):4503-4514. PubMed ID: 31289131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: role of the S100A4-miR155-SOCS1-MMP9 axis.
    Yan XL; Jia YL; Chen L; Zeng Q; Zhou JN; Fu CJ; Chen HX; Yuan HF; Li ZW; Shi L; Xu YC; Wang JX; Zhang XM; He LJ; Zhai C; Yue W; Pei XT
    Hepatology; 2013 Jun; 57(6):2274-86. PubMed ID: 23316018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy of sorafenib with mesenchymal stem cells as a novel cancer treatment regimen in xenograft models of hepatocellular carcinoma.
    Seyhoun I; Hajighasemlou S; Muhammadnejad S; Ai J; Nikbakht M; Alizadeh AA; Hosseinzadeh F; Mirmoghtadaei M; Seyhoun SM; Verdi J
    J Cell Physiol; 2019 Jun; 234(6):9495-9503. PubMed ID: 30362607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.